Annals of Oncology: Editor's Choice

You will find below links to the Annals of Oncology's 'Editor's Choice' articles - new category introduced in 2014 of articles selected by Jean-Charles Soria, Annals of Oncology Editor-in-Chief. These articles are open access to all!

Please note that although the articles are chosen for each new edition of the Annals of Oncology, the dates mentioned below are the first published online dates which may differ from the journal edition's publication date.

Filter

Date Title Topic
22 Dec 2016 Validation and development of MTH1 inhibitors for treatment of cancer Anti-Cancer Agents & Biologic Therapy
22 Dec 2016 Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase... Cancer Immunology and Immunotherapy , Non-Small-Cell Lung Cancer, Metastatic
22 Dec 2016 Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized,... Cancer Immunology and Immunotherapy , Gastrointestinal Cancers
22 Dec 2016 ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chron... Lymphomas
26 Sep 2016 Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers Breast Cancer, Metastatic
15 Sep 2016 Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibito... Melanoma and other Skin Tumours
29 Aug 2016 Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial Anti-Cancer Agents & Biologic Therapy , Colon Cancer
08 Aug 2016 Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues Ovarian Cancer
08 Aug 2016 Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape Non-Small-Cell Lung Cancer, Locally Advanced , Non-Small-Cell Lung Cancer, Metastatic
08 Aug 2016 Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally... Breast Cancer, Metastatic , Cancer Immunology and Immunotherapy
25 Jul 2016 Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the A... Ovarian Cancer
12 Jul 2016 Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066... Cancer Immunology and Immunotherapy , Melanoma and other Skin Tumours
05 Jul 2016 ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Colon Cancer , Rectal Cancer
29 Jun 2016 Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progres... Breast Cancer, Metastatic , Biomarkers
29 Jun 2016 Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colo... Colon Cancer , Rectal Cancer , Biomarkers